NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
02/06/2026
Voltar para busca
Dado oficial do USPTO
REMISOL ADVANCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
REMISOL ADVANCE
ST13
US500000079241646Classe
9, 10, 35, 42, 44
Pedido
79241646
Registro
5992975
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
23/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10, 35, 42, 44
Data de depósito
16/07/2018
Data de registro
25/02/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/06/2026
Última transação
23/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
DUBOIS, MICHELLE
Localização atual
Historical data usage
Titulares e representantes
Titulares
NORMAND-INFO S.A.S.
Representantes
Jessica G. McDonald Schwegman Lundberg & Woessner P.A.
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Computer system comprised primarily of computer hardware and Computer software used for managing data from medical analysis automatons in all fields of laboratory workprograms for generating requestsprocessing and validating patient results by means of rules utilizing several parametersprinting quantitative or qualitative results in different formatsmonitoring quality control as well as providing numerous statistics and ensuring result traceability in the fields of chemistryimmunoassayelectrophoresishematologycytometry and coagulation
Classe 10
Medical apparatus and instruments for use in clinical laboratoriesnamely medical diagnostic analyzers for use in the field of hematology; Medical apparatus and instruments for use in clinical laboratoriesanalyzers for diagnostic medical use in the fields of chemistryimmunoassayelectrophoresiscytometry and coagulation
Classe 35
Advertising; business management; business management and administration; office functions
Classe 42
Scientific research; scientific and technological design in the field of chemistryimmunoassayelectrophoresishematologycytometrycoagulation; technological research in the field of chemistryimmunoassayelectrophoresishematologycytometrycoagulation; industrial analysis and research in the field of chemistryimmunoassayelectrophoresishematologycytometrycoagulation; design and development of computer software; design and development of computer firmware; design and development of computer software related to medical analysis services; design and development of computer firmware related to medical analysis services
Classe 44
Medical analysis services in the field of chemistryimmunoassayelectrophoresishematologycytometrycoagulation
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
02/06/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/06/2026
ES75
TEAS SECTION 71 & 15 RECEIVED
09/02/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
25/02/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/07/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/06/2020
FIMP
FINAL DISPOSITION PROCESSED
25/06/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/05/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
25/02/2020
GPNX
NOTIFICATION PROCESSED BY IB
20/12/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/12/2019
PUBO
PUBLISHED FOR OPPOSITION
10/12/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/12/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
17/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/09/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/06/2019
GNRT
NON-FINAL ACTION E-MAILED
13/06/2019
CNRT
NON-FINAL ACTION WRITTEN
13/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/06/2019
ALIE
ASSIGNED TO LIE
03/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/05/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/05/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/05/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/02/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/01/2019
RFNP
REFUSAL PROCESSED BY IB
15/12/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/11/2018
RFRR
REFUSAL PROCESSED BY MPU
28/11/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/11/2018
CNRT
NON-FINAL ACTION WRITTEN
08/11/2018
DOCK
ASSIGNED TO EXAMINER
01/11/2018
MAFR
APPLICATION FILING RECEIPT MAILED
06/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/10/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/09/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace REMISOL ADVANCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.